null
ChEBI ID: 26375
Member | Definition | Role |
---|---|---|
2-amino-3-methyl-7-(2-phenylethyl)-5H-pteridine-4,6-dione | 2-amino-3-methyl-7-(2-phenylethyl)-5H-pteridine-4,6-dione | |
2-amino-4-hydroxy-6-formylpteridine | Pterin carrying a formyl group at position 6. | 6-formylpterin |
2-amino-4-hydroxy-6,7-dimethyl-5,6,7,8-tetrahydropteridine | 6,7-Dimethyltetrahydropterin | |
6-methyltetrahydropterin | 6-Methyltetrahydropterin | |
7,8-dihydropterin | 7,8-dihydropterin; PH4 | |
tatiopterin | A pterin derivative that is an aspartyl derivative of sarcinapterin with a 7-proton instead of a 7-methyl group in the methanopterin moiety. | tatiopterin |
urothion | Urothion |
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 56 (38.10) | 18.7374 |
1990's | 31 (21.09) | 18.2507 |
2000's | 43 (29.25) | 29.6817 |
2010's | 15 (10.20) | 24.3611 |
2020's | 2 (1.36) | 2.80 |
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 1 (0.68%) | 5.53% |
Reviews | 2 (1.35%) | 6.00% |
Case Studies | 5 (3.38%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 140 (94.59%) | 84.16% |